Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed on September 25, 2025, and announced on September 26, 2025.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margin, or debt metrics. It focuses exclusively on share repurchase activity and capital structure updates:
- Shares Purchased: 2,318,700 ordinary shares.
- Price Range: Highest price paid was 329.70 pence; lowest was 325.90 pence.
- Average Price: Volume weighted average price paid was 327.8536 pence.
- Treasury Shares: Following settlement, 38,908,103 shares are held as treasury shares.
- Voting Rights: The number of ordinary shares with voting rights is 8,913,445,545.
- Registered Capital: Total registered share capital is 8,952,353,648 ordinary shares of £0.01 each.
Material Changes
The primary material change is the reduction of outstanding voting shares due to the second tranche of the share buyback programme announced on July 31, 2025. The company intends to hold the purchased shares as treasury shares.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction.
Investor Verification Checklist
- Verify the total number of shares purchased under the second tranche of the buyback programme (2,318,700).
- Confirm the updated count of treasury shares (38,908,103) and voting shares (8,913,445,545).
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Check the company website (www.haleon.com/investors) for the official announcement and trade breakdown.